Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

18F-Fluoromethylcholine-positron emission tomography/computed tomography for diagnosing bone and lymph node metastases in patients with intermediate- or high-risk prostate cancer.

Mortensen MA, Poulsen MH, Gerke O, Jakobsen JS, Høilund-Carlsen PF, Lund L.

Prostate Int. 2019 Sep;7(3):119-123. doi: 10.1016/j.prnil.2019.01.002. Epub 2019 Jan 19.

2.

Does therapy of the primary tumor matter in oligometastatic prostate cancer? A prospective 10-year follow-up study.

Poulsen MH, Jakobsen JS, Mortensen MA, Høilund-Carlsen PF, Lund L.

Res Rep Urol. 2019 Jul 30;11:215-221. doi: 10.2147/RRU.S190140. eCollection 2019.

3.

Mutant CEBPA directly drives the expression of the targetable tumor-promoting factor CD73 in AML.

Jakobsen JS, Laursen LG, Schuster MB, Pundhir S, Schoof E, Ge Y, d'Altri T, Vitting-Seerup K, Rapin N, Gentil C, Jendholm J, Theilgaard-Mönch K, Reckzeh K, Bullinger L, Döhner K, Hokland P, Fitzgibbon J, Porse BT.

Sci Adv. 2019 Jul 10;5(7):eaaw4304. doi: 10.1126/sciadv.aaw4304. eCollection 2019 Jul.

4.

Accurate Recycling of Parental Histones Reproduces the Histone Modification Landscape during DNA Replication.

Reverón-Gómez N, González-Aguilera C, Stewart-Morgan KR, Petryk N, Flury V, Graziano S, Johansen JV, Jakobsen JS, Alabert C, Groth A.

Mol Cell. 2018 Oct 18;72(2):239-249.e5. doi: 10.1016/j.molcel.2018.08.010. Epub 2018 Aug 23.

5.

Enhancer and Transcription Factor Dynamics during Myeloid Differentiation Reveal an Early Differentiation Block in Cebpa null Progenitors.

Pundhir S, Bratt Lauridsen FK, Schuster MB, Jakobsen JS, Ge Y, Schoof EM, Rapin N, Waage J, Hasemann MS, Porse BT.

Cell Rep. 2018 May 29;23(9):2744-2757. doi: 10.1016/j.celrep.2018.05.012.

6.

Noninvasive Detection of High Grade Prostate Cancer by DNA Methylation Analysis of Urine Cells Captured by Microfiltration.

Larsen LK, Jakobsen JS, Abdul-Al A, Guldberg P.

J Urol. 2018 Oct;200(4):749-757. doi: 10.1016/j.juro.2018.04.067. Epub 2018 Apr 24.

PMID:
29702096
7.

C/EBPα creates elite cells for iPSC reprogramming by upregulating Klf4 and increasing the levels of Lsd1 and Brd4.

Di Stefano B, Collombet S, Jakobsen JS, Wierer M, Sardina JL, Lackner A, Stadhouders R, Segura-Morales C, Francesconi M, Limone F, Mann M, Porse B, Thieffry D, Graf T.

Nat Cell Biol. 2016 Apr;18(4):371-81. doi: 10.1038/ncb3326. Epub 2016 Mar 14.

PMID:
26974661
8.

Amplification of pico-scale DNA mediated by bacterial carrier DNA for small-cell-number transcription factor ChIP-seq.

Jakobsen JS, Bagger FO, Hasemann MS, Schuster MB, Frank AK, Waage J, Vitting-Seerup K, Porse BT.

BMC Genomics. 2015 Feb 5;16:46. doi: 10.1186/s12864-014-1195-4.

9.

TGIF1 is a negative regulator of MLL-rearranged acute myeloid leukemia.

Willer A, Jakobsen JS, Ohlsson E, Rapin N, Waage J, Billing M, Bullinger L, Karlsson S, Porse BT.

Leukemia. 2015 May;29(5):1018-31. doi: 10.1038/leu.2014.307. Epub 2014 Oct 28.

PMID:
25349154
10.

C/EBPα is required for long-term self-renewal and lineage priming of hematopoietic stem cells and for the maintenance of epigenetic configurations in multipotent progenitors.

Hasemann MS, Lauridsen FK, Waage J, Jakobsen JS, Frank AK, Schuster MB, Rapin N, Bagger FO, Hoppe PS, Schroeder T, Porse BT.

PLoS Genet. 2014 Jan;10(1):e1004079. doi: 10.1371/journal.pgen.1004079. Epub 2014 Jan 9.

11.

Spine metastases in prostate cancer: comparison of technetium-99m-MDP whole-body bone scintigraphy, [(18) F]choline positron emission tomography(PET)/computed tomography (CT) and [(18) F]NaF PET/CT.

Poulsen MH, Petersen H, Høilund-Carlsen PF, Jakobsen JS, Gerke O, Karstoft J, Steffansen SI, Walter S.

BJU Int. 2014 Dec;114(6):818-23. doi: 10.1111/bju.12599. Epub 2014 May 22.

12.

Endoluminal pharmacologic stimulation of the upper urinary tract.

Jakobsen JS.

Dan Med J. 2013 May;60(5):B4642. Review.

PMID:
23673271
13.

Temporal mapping of CEBPA and CEBPB binding during liver regeneration reveals dynamic occupancy and specific regulatory codes for homeostatic and cell cycle gene batteries.

Jakobsen JS, Waage J, Rapin N, Bisgaard HC, Larsen FS, Porse BT.

Genome Res. 2013 Apr;23(4):592-603. doi: 10.1101/gr.146399.112. Epub 2013 Feb 12.

14.

Mammalian tissues defective in nonsense-mediated mRNA decay display highly aberrant splicing patterns.

Weischenfeldt J, Waage J, Tian G, Zhao J, Damgaard I, Jakobsen JS, Kristiansen K, Krogh A, Wang J, Porse BT.

Genome Biol. 2012 May 24;13(5):R35. doi: 10.1186/gb-2012-13-5-r35.

15.

UPF2 is a critical regulator of liver development, function and regeneration.

Thoren LA, Nørgaard GA, Weischenfeldt J, Waage J, Jakobsen JS, Damgaard I, Bergström FC, Blom AM, Borup R, Bisgaard HC, Porse BT.

PLoS One. 2010 Jul 19;5(7):e11650. doi: 10.1371/journal.pone.0011650.

16.

Endoluminal isoproterenol reduces renal pelvic pressure during semirigid ureterorenoscopy: a porcine model.

Jakobsen JS, Jung HU, Gramsbergen JB, Osther PJ, Walter S.

BJU Int. 2010 Jan;105(1):121-4. doi: 10.1111/j.1464-410X.2009.08678.x. Epub 2009 Jun 24.

17.

A systematic analysis of Tinman function reveals Eya and JAK-STAT signaling as essential regulators of muscle development.

Liu YH, Jakobsen JS, Valentin G, Amarantos I, Gilmour DT, Furlong EE.

Dev Cell. 2009 Feb;16(2):280-91. doi: 10.1016/j.devcel.2009.01.006.

18.

Endoluminal norepinephrine inhibits smooth muscle activity of the pig pyeloureter by stimulation of beta-adrenoceptors without side effects.

Mortensen J, Holst U, Jakobsen JS, Andreasen F.

Basic Clin Pharmacol Toxicol. 2008 Nov;103(5):455-60. doi: 10.1111/j.1742-7843.2008.00297.x. Epub 2008 Aug 15.

19.

Temporal ChIP-on-chip reveals Biniou as a universal regulator of the visceral muscle transcriptional network.

Jakobsen JS, Braun M, Astorga J, Gustafson EH, Sandmann T, Karzynski M, Carlsson P, Furlong EE.

Genes Dev. 2007 Oct 1;21(19):2448-60.

20.

Irrigation with isoproterenol diminishes increases in pelvic pressure without side-effects during ureterorenoscopy: a randomized controlled study in a porcine model.

Jung HU, Jakobsen JS, Mortensen J, Osther PJ, Djurhuus JC.

Scand J Urol Nephrol. 2008;42(1):7-11. Epub 2007 Sep 6.

PMID:
17853047
21.

Irrigation with isoproterenol during ureterorenoscopy causes no systemic side-effects.

Jung HU, Jakobsen JS, Frimodt-Moeller PC, Osther PJ.

Scand J Urol Nephrol. 2008;42(2):158-63.

PMID:
17853007
22.

Local and systemic effects of endoluminal pelvic perfusion of isoproterenol: a dose response investigation in pigs.

Jakobsen JS, Holst U, Jakobsen P, Steen W, Mortensen J.

J Urol. 2007 May;177(5):1934-8.

PMID:
17437851
23.
24.

Bacterial postgenomics: the promise and peril of systems biology.

Suen G, Jakobsen JS, Goldman BS, Singer M, Garza AG, Welch RD.

J Bacteriol. 2006 Dec;188(23):7999-8004. Epub 2006 Sep 22. No abstract available.

25.

A temporal map of transcription factor activity: mef2 directly regulates target genes at all stages of muscle development.

Sandmann T, Jensen LJ, Jakobsen JS, Karzynski MM, Eichenlaub MP, Bork P, Furlong EE.

Dev Cell. 2006 Jun;10(6):797-807.

26.

Sigma54 enhancer binding proteins and Myxococcus xanthus fruiting body development.

Jakobsen JS, Jelsbak L, Jelsbak L, Welch RD, Cummings C, Goldman B, Stark E, Slater S, Kaiser D.

J Bacteriol. 2004 Jul;186(13):4361-8.

27.

Molecular mechanism of AMD3100 antagonism in the CXCR4 receptor: transfer of binding site to the CXCR3 receptor.

Rosenkilde MM, Gerlach LO, Jakobsen JS, Skerlj RT, Bridger GJ, Schwartz TW.

J Biol Chem. 2004 Jan 23;279(4):3033-41. Epub 2003 Oct 28.

28.
29.

Metal ion enhanced binding of AMD3100 to Asp262 in the CXCR4 receptor.

Gerlach LO, Jakobsen JS, Jensen KP, Rosenkilde MR, Skerlj RT, Ryde U, Bridger GJ, Schwartz TW.

Biochemistry. 2003 Jan 28;42(3):710-7.

PMID:
12534283
30.

Host factor I, Hfq, binds to Escherichia coli ompA mRNA in a growth rate-dependent fashion and regulates its stability.

Vytvytska O, Jakobsen JS, Balcunaite G, Andersen JS, Baccarini M, von Gabain A.

Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14118-23.

31.
32.

Influence of Lewis alpha1-3/4-L-fucosyltransferase (FUT3) gene mutations on enzyme activity, erythrocyte phenotyping, and circulating tumor marker sialyl-Lewis a levels.

Orntoft TF, Vestergaard EM, Holmes E, Jakobsen JS, Grunnet N, Mortensen M, Johnson P, Bross P, Gregersen N, Skorstengaard K, Jensen UB, Bolund L, Wolf H.

J Biol Chem. 1996 Dec 13;271(50):32260-8.

Supplemental Content

Loading ...
Support Center